Evolving European guidance on the medical management of neovascular age related macular degeneration.

Evolving European guidance on the medical management of neovascular age related macular degeneration.

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in develop...

Full description

Bibliographic Details
Main Authors:	Chakravarthy, U, Soubrane, G, Bandello, F, Chong, V, Creuzot-Garcher, C, Dimitrakos, SA, Korobelnik, J, Larsen, M, Monés, J, Pauleikhoff, D, Pournaras, C, Staurenghi, G, Virgili, G, Wolf, S
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
by: Spaide, Richard F., et al.
Published: (2021)

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
by: Chakravarthy, U, et al.
Published: (2012)

Radiotherapy for neovascular age-related macular degeneration.
by: Evans, JR, et al.
Published: (2010)

Optical coherence tomography in neovascular age-related macular degeneration
by: Chong, V
Published: (2012)

Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration
by: Mendonça, Luísa SM, et al.
Published: (2022)

Colour photographs for screening in neovascular age-related macular degeneration: are they necessary?
by: Hibbs, S, et al.
Published: (2011)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
by: Sivaprasad, S, et al.
Published: (2011)

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
by: Morohoshi, K, et al.
Published: (2012)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: Ninety-six-week results of the VIEW studies
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2007)

Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration
by: Jia, Yali, et al.
Published: (2015)

Long-Term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with Ranibizumab
by: Menke, Marcel N., et al.
Published: (2013)

Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study
by: Hernandez, R, et al.
Published: (2021)

Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2005)

Pharmacogenetic Associations with Vascular Endothelial Growth Factor Inhibition in Participants with Neovascular Age-Related Macular Degeneration in the IVAN Study
by: Lotery, A, et al.
Published: (2013)

Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the ivan study
by: Lotery, A, et al.
Published: (2013)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
by: Chakravarthy, U, et al.
Published: (2012)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
by: Chakravarthy, U, et al.
Published: (2012)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
by: von der Emde, L, et al.
Published: (2019)

Treat-And-extend bevacizumab for neovascular age-related macular degeneration: The importance of baseline characteristics
by: Rush, R, et al.
Published: (2014)

Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
by: Banister, K, et al.
Published: (2022)

Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians vs Chinese.
by: Sivaprasad, S, et al.
Published: (2006)

Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration
by: Ma, X, et al.
Published: (2024)

Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings
by: Holz, F, et al.
Published: (2017)

rs10737680 polymorphism in complement factor H and neovascular age-related macular degeneration in Yogyakarta, Indonesia
by: Sigalingging, Talenta, et al.
Published: (2022)

Association of the HtrA1 rs11200638 Polymorphism with Neovascular Age-Related Macular Degeneration in Indonesia
by: Supanji, Supanji, et al.
Published: (2021)

Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.
by: Pearce, E, et al.
Published: (2011)

Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
by: Jackson, TL, et al.
Published: (2024)

Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
by: Saleh, Rafidah, et al.
Published: (2017)

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration.
by: Chen, F, et al.
Published: (2009)

The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration
by: Levine, Emily S., et al.
Published: (2020)

The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration
by: Levine, Emily S, et al.
Published: (2021)

SPATIAL DISTRIBUTION OF CHORIOCAPILLARIS IMPAIRMENT IN EYES WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Quantitative OCT Angiography Study
by: Moult, Eric M, et al.
Published: (2021)

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
by: Ross, A, et al.
Published: (2013)

The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease
by: Taylor, J, et al.
Published: (2015)

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
by: Borchert, GA, et al.
Published: (2024)

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-Related Macular Degeneration
by: Heier, J, et al.
Published: (2012)